Claims
- 1. A compound of the formulaAr—A—(HCR1)—X—Y (I), wherein:A denotes an ethynylene group, R1 denotes a hydrogen atom or a C1-3-alkyl group, Ar denotes a phenyl group substituted by the groups R2 to R4, whilst R2 denotes a phenyl or phenoxy group, a C1-3-alkyl group which may be substituted by a phenyl, phenylamino, N-(C1-3-alkyl)-phenylamino or N-(C1-3alkanoyl)-phenylamino group, a carboxy or C1-3-alkoxycarbonyl group, a benzoyl or phenylsulphonyl group wherein in each case the phenyl moiety may additionally be substituted by a fluorine, chlorine or bromine atom, by a methyl, methoxy, carboxy or C1--alkoxycarbonyl group, whilst in the above-mentioned benzoyl groups the oxygen atom may additionally be replaced by a carboxy-C1-3-alkoxyimino or C1-3-alk-oxycarbonyl-C1-3-alkoxyimino group, a C1-5-alkylamino group which may be substituted in the alkyl moiety by a phenyl, carboxy, C1-3-alkoxycarbonyl, carboxy-C1-3-alkylaminocarbonyl, C1-3-alkoxycarbonyl-C1-3-alkylaminocarbonyl, N-(C1-3-alkyl)carboxy-C1-3-alkylaminocarbonyl or N-(C1-3-alkyl)-C1-3-alkoxycarbonyl-C1-3-alkylaminocarbonyl group, or a C3-7-cycloalkylamino group, whilst the above-mentioned groups may each additionally be substituted at the amino nitrogen atom by a C3-7-cycloalkanoyl, benzoyl or phenylsulphonyl group, by a carboxy-C1-3-alkylcarbonyl or C1-3-alkoxycarbonyl-C1-3-alkylcarbonyl group wherein the alkyl moiety of the alkylcarbonyl group is substituted in each case by an amino or trifluoroacetylamino group, by a C2-4-alkanoyl group, which may be substituted in the alkanoyl moiety by an amino, carboxy, C1-3-alkoxycarbonyl, carboxy-C1-3-alkoxy, C1-3-alkoxycarbonyl-C1-3-alkoxy, carboxy-C1-3-alkylaminocarbonyl, C1-3-alkoxycarbonyl-C1-3-alkylaminocarbonyl, N-(C1-3-alkyl)-carboxy-C1-3-alkylaminocarbonyl or N-(C1-3-alkyl)-C1-3-alkoxycarbonyl-C1-3-alkylaminocarbonyl group, by a carboxy-C1-2-alkylaminocarbonyl, C1-3-alkoxycarbonyl-C1-2-alkylaminocarbonyl, carboxy-C1-3-alkylaminocarbonyl-C1-2-alkylaminocarbonyl or C1-3-alkoxycarbonyl-C1-3-alkylaminocarbonyl-C1-2-alkylaminocarbonyl group, a formyl, pyridylcarbonyl, thienylcarbonyl, imidazolylcarbonyl, 1-methyl-imidazolylcarbonyl, thiazolylcarbonyl or indolylcarbonyl group, a benzimidazol-1-yl, benzimidazol-1-yl-methyl or 5-oxo-4,5-dihydro-pyrazol-3-yl group optionally substituted by 1 or 2 methyl groups, a pyrazol-1-yl group substituted by a phenyl group, by a phenyl group and a C1-4-alkyl group or by one or two C1-4-alkyl groups wherein an alkyl substituent may at the same time be substituted by a carboxy or C1-3-alkoxycarbonyl group, or a carbonyl group which is substituted by a C1-5-alkyl group optionally substituted by a carboxy or C1-3-alkoxycarbonyl group, by a C3-7-cycloalkyl group, by an amino or C1-5-alkylamino group, which are in each case substituted at the amino nitrogen atom by a C1-3-alkyl group which may be substituted by a C3-7-cycloalkyl, phenyl, pyrrolidinyl or pyridinyl group or in the 2 or 3 position by a di-(C1-3-alkyl)-amino group, or by a di-(C1-3-alkyl)-amino group, by a carboxy-C1-3-alkylamino or C1-3-alkoxycarbonyl-C1-3-alkylamino group which is in each case substituted at the amino nitrogen atom by a pyrazolyl group optionally substituted by a C1-3-alkyl group, by a 3- to 7-membered cycloalkyleneimino group which may be substituted by one or two C1-3-alkyl groups, whilst the above-mentioned pyrrolidino groups optionally substituted by a methyl group may additionally be substituted by a hydroxymethyl, carboxy, C1-3-alkoxycarbonyl, carboxy-C1-3-alkyl, C1-3-alkoxycarbonyl-C1-3-alkyl, carboxy-C1-3-alkyloxy-C1-3-alkyl, C1-3-alkoxycarbonyl-C1-3-alkyloxy-C1-3-alkyl, carboxy-C1-3-alkylamino-C1-3-alkyl, N-(C-1-3-alkyl)-carboxy-C1-3-alkylamino-C1-3-alkyl, C1-3-alkoxycarbonyl-C1-3-alkylamino-C1-3-alkyl, N-(C1-3-alkyl)-carboxy-C1-3-alkylamino-C1-3-alkyl or N-(C1-3-alkyl)-C1-3-alkoxycarbonyl-C1-3-alkylamino-C1-3-alkyl group, by a morpholino, piperazino, 4-methyl-piperazino, piperazino-C1-3-alkyl, dihydropyrazolo, tetrahydropyrazolo, tetrahydroisoxazolo or 7-azabicycloheptyl group or by a N-(C1-3-alkyl)phenyl or N-(C1-3-alkyl)-pyridylamino group optionally substituted in the alkyl moiety by a carboxy or C1-3-alkoxycarbonyl group, R3 denotes a hydrogen, fluorine, chlorine or bromine atom, a hydroxy, C1-3-alkoxy, trifluoromethyl, amino or C2-3-alkanoylamino group, a C1-3-alkyl group which may be substituted by a hydroxy, carboxy, C1-3-alkoxycarbonyl, carboxy-C1-3-alkoxy, C1-3-alkoxycarbonyl-C1-3-alkoxy, carboxy-C1-3alkylaminocarbonyl, C1-3-alkoxycarbonyl-C1-3-alkylaminocarbonyl, N-(C1-3-alkyl)-carboxy-C1-3-alkylaminocarbonyl or N-(C1-3-alkyl)-C1-3-alkoxycarbonyl-C1-3-alkylaminocarbonyl group, a C1-3-alkyl group which is substituted by a carboxy-C1-3-alkylamino, C1-3-alkoxycarbonyl-C1-3-alkylamino, N-(C1-3-alkyl)-carboxy-C1-3-alkylamino or C1-3-alkoxycarbonyl-C1-3-alkylaminocarbonyl group, a C2-3-alkenyl group substituted by a carboxy or C1-3-alkoxycarbonyl group or a carbimino group optionally substituted at the carbon atom by a C1-3-alkyl group, which is substituted at the imino nitrogen atom by a carboxy-C1-3-alkoxy, C1-3-alkoxycarbonyl-C1-3-alkoxy or aminocarbonylamino group, or R2 and R3 together denote a —CO—O—CH2-group and R4 denotes a hydrogen, fluorine, chlorine or bromine atom, a C1-3-alkyl or trifluoromethyl group, X denotes an —NH-group optionally substituted by a Cb 1-3-alkyl group and Y denotes a cyclohexyl group substituted by an amino group, a phenylene group substituted by an amidino group, which may be substituted by a benzoyl or C1-8-alkoxycarbonyl group, whilst the above-mentioned phenylene group may be substituted by a methyl or methoxy group, or a tautomer or salt thereof.
- 2. A compound of the formula whereinA denotes an ethynylene group, X denotes an —NH— group optionally substituted by a methyl group, R2 denotes a C1-4-alkylcarbonylamino or C3-5-cycloalkylcarbonylamino group, which is substituted in each case at the amino nitrogen atom by a carboxy-C1-2-alkyl, C1-3-alkoxycarbonyl-C1-2-alkyl, carboxy-C1-2-alkylaminocarbonyl-C1-2-alkyl or C1-3-alkoxycarbonyl-C1-2-alkylaminocarbonyl-C1-2-alkyl group, a C1-4-alkylamino or C3-5-cycloalkylamino group, which is substituted in each case at the amino nitrogen atom by a carboxy-C1-3-alkylcarbonyl, C1-3-alkoxycarbonyl-C1-3-alkylcarbonyl, carboxy-C1-2-alkylaminocarbonyl-C1-2-alkylcarbonyl, C1-3-alkoxycarbonyl-C1-2-alkylaminocarbonyl-C1-2-alkylcarbonyl, carboxy-C1-2-alkylaminocarbonyl, C1-3-alkoxycarbonyl-C1-2-alkylaminocarbonyl, carboxy-C1-2-alkylaminocarbonyl-C1-2-alkylaminocarbonyl or C1-3-alkoxycarbonyl-C1-2-alkylaminocarbonyl-C1-2-alkylaminocarbonyl group optionally substituted in the alkyl moiety by an amino group, or by a carboxymethyloxymethylcarbonyl, C1-3-alkoxycarbonyl-methyloxymethylcarbonyl, carboxymethylaminomethylcarbonyl, C1-3-alkoxycarbonyl-methylaminomethylcarbonyl, N-methyl-carboxymethylaminomethylcarbonyl, N-methyl-C1-3-alkoxycarbonyl-carboxymethylaminomethylcarbonyl, aminomethylcarbonyl, 2-amino-ethylcarbonyl, carboxy-C1-2-alkylaminocarbonylmethyloxymethylcarbonyl, C1-3-alkoxycarbonyl-C1-2-alkylaminocarbonylmethyloxymethylcarbonyl, carboxy-C1-2-alkylaminocarbonylmethylaminomethylcarbonyl, C1-3-alkoxycarbonyl-C1-2-alkylaminocarbonylmethylaminomethylcarbonyl, N-methyl-carboxy-C1-2-alkylaminocarbonylmethylaminomethylcarbonyl or N-methyl-C1-3-alkoxycarbonyl-C1-2-alkylaminocarbonylmethylaminomethylcarbonyl group, or a carbonyl group which is substituted by a cyclopentyl group, by a C3-5-alkyl group which may additionally be substituted by a carboxy or C1-3-alkoxycarbonyl group, by a C1-4-alkylamino, phenylamino or pyridylamino group substituted at the amino nitrogen atom by a C1-4-alkyl, carboxy-C1-3-alkyl or C1-3-alkoxycarbonyl-C1-3-alkyl group, by a pyrrolidino group substituted by a methyl, hydroxymethyl, amino, carboxy, C1-3-alkoxycarbonyl, carboxy-C1-2-alkyl, C1-3-alkoxycarbonyl-C1-2-alkyl, carboxymethyloxymethyl, C1-3-alkoxycarbonylmethyloxymethyl, carboxymethylaminomethyl, C1-3-alkoxycarbonyl-methylaminomethyl, carboxy-methylaminocarbonylmethyloxymethyl or C1-3-alkoxycarbonylmethylaminocarbonylmethyloxymethyl group, R3 denotes a hydrogen, fluorine, chlorine or bromine atom or a trifluoromethyl group, a C1-2-alkyl group optionally substituted by a hydroxy, carboxy, C1-3-alkoxycarbonyl, carboxymethyloxy, C1-3-alkoxycarbonyl-methyloxy, carboxymethylamino, N-methyl-carboxymethylamino, C1-3-alkoxycarbonylmethylamino, N-methyl-C1-3-alkoxycarbonyl-methylamino, carboxymethylaminocarbonyl or C1-3-alkoxycarbonylmethylaminocarbonyl group, a vinyl group substituted by a carboxy or C1-3-alkoxycarbonyl group, R4 denotes a hydrogen, fluorine, chlorine or bromine atom, a methyl, ethyl or trifluoromethyl group and Y denotes an amidino group optionally substituted by a C1-8-alkoxycarbonyl or benzoyl group, or a tautomer or salt thereof.
- 3. A compound of the formula Ia according to claim 2, whereinA denotes an ethynylene group, X denotes an —NH— group, R2 denotes a C1-4-alkylaminocarbonyl group, which is substituted in each case at the amino nitrogen atom by a carboxy-C1-2-alkyl or C1-3-alkoxycarbonyl-C1-2-alkyl group, a C1-4alkylamino group which is substituted at the amino nitrogen atom by a carboxy-C1-3-alkylcarbonyl, C1-3-alkoxycarbonyl-C1-3-alkylcarbonyl, carboxy-C1-2-alkylaminocarbonyl or C1-3-alkoxycarbonyl-C1-2-alkylaminocarbonyl group, or a carbonyl group which is substituted by a C3-5-alkyl group which may additionally be substituted by a carboxy or C1-3-alkoxycarbonyl group, by a C1-4-alkylamino or pyridylamino group substituted at the amino nitrogen atom by a carboxy-C1-3-alkyl or C1-3-alkoxycarbonyl-C1-3-alkyl group, by a pyrrolidino group optionally substituted by a methyl group, R3 denotes a C1-2-alkyl group optionally substituted by a carboxy or C1-3-alkoxycarbonyl group, R4 denotes a hydrogen atom or a methyl group and Y denotes an amidino group optionally substituted by a C1-8-alkoxycarbonyl or benzoyl group, or a tautomer or salt thereof.
- 4. A compound selected from the group consisting of:(a) rac-4-{3-[5-ethoxycarbonylmethyl-2-methyl-4-(2-methyl-pyrrolidinocarbonyl)-phenyl]-propargylamino}benzamidine, (b) rac-4-{3-[2,5-dimethyl-4-(2-methyl-pyrrolidinocarbonyl)-phenyl]-propargylamino}benzamidine, (c) 4-[3-(2,5-dimethyl-4-isopropylcarbonyl-phenyl)propargyl-amino]benzamidine, (d) 4-{3-[2,5-dimethyl-4-(N-methyl-N-pyridin-2-yl-aminocarbonyl)-phenyl]propargylamino)}benzamidine, (e) 4-{3-[2,5-dimethyl-4-(N-methyl-N-pyridin-2-yl-amino-carbonyl)-phenyl]prop-1-ylamino}benzamidine, (f) 4-[3-(3-methyl-4-pyrrolidinocarbonyl-phenyl)-propargyl-amino]-benzamidine, (g) 4-{3-[2,5-dimethyl-4-(N-(2-methoxycarbonyl-ethyl)-N-ethyl-carbonylamino)-phenyl]-propargylamino}benzamidine, (h) 4-{3-[2,5-dimethyl-4-(N-isopropyl-N-hydroxycarbonylmethyl-aminocarbonyl-amino)-phenyl]-propargylamino}-benzamidine and (i) 4-{3-[2,5-dimethyl-4-(N-isopropyl-N-hydroxycarbonylmethyl-carbonyl-amino)-phenyl]-propargylamino}-benzamidine or a salt thereof.
- 5. A physiologically acceptable salt of a compound according to claim 1, 2 or 3, wherein Y does not contain a cyano group, or of a compound according to claim 4.
- 6. A pharmaceutical composition comprising a compound according to claim 1, 2 or 3, wherein Y does not contain a cyano group, or a compound according to claim 4, or a physiologically acceptable salt thereof, together with a pharmaceutically acceptable carriers or diluent.
- 7. A method of treating a patient to prolong the thrombin time in such patient, which method comprises administering to such patient a thrombin time prolonging amount of a compound according to claim 1, 2 or 3, wherein Y does not contain a cyano group, or a compound according to claim 4, or a physiologically acceptable salt thereof.
Priority Claims (2)
Number |
Date |
Country |
Kind |
198 58 029 |
Dec 1998 |
DE |
|
199 48 101 |
Oct 1999 |
DE |
|
Parent Case Info
This application is derived from International Application PCT/EP99/09921 pursuant to 35 U.S.C. 371.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
PCT/EP99/09921 |
|
WO |
00 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO00/35859 |
6/22/2000 |
WO |
A |
Foreign Referenced Citations (3)
Number |
Date |
Country |
0 760 364 |
Mar 1997 |
EP |
0 805 149 |
Nov 1997 |
EP |
WO95 18111 |
Jul 1995 |
WO |